MUJEEB U. SIDDIQUI, DO

HANNIBAL, MO

Research Active
Surgery NPI registered 21+ years 50 publications 2024 – 2026 NPI: 1619974797
MiceCell Line, TumorPrognosisAlgorithmsNeoplasmsAntineoplastic AgentsBrainAntineoplastic Combined Chemotherapy ProtocolsSensitivity and SpecificityNeoplasm Recurrence, LocalMitochondriaMultiple MyelomaAntibodies, BispecificNeuroprotective AgentsStandard of Care

Practice Location

6500 HOSPITAL DR
HANNIBAL, MO 63401-6890

Phone: (573) 629-3400

What does MUJEEB SIDDIQUI research?

Dr. Siddiqui studies the challenges patients face during medical transitions, particularly when leaving the emergency department. His research highlights how doctors often overlook important factors that can help patients manage their health at home. He also delves into specific diseases like AL amyloidosis and multiple myeloma, exploring how different treatment options affect patient survival and quality of life. Dr. Siddiqui is also involved in understanding how technologies, such as deep learning, can enhance disaster response, including mapping landslide risks, and the implications of brain health in Alzheimer's disease treatment.

Key findings

  • In a study of emergency department discharges, 59% of patients reported difficulties understanding medical instructions, compared to only 37.6% of doctors recognizing this issue.
  • Patients with minimal bone marrow involvement in solitary bone plasmacytoma had a 92% progression rate to multiple myeloma, compared to 76% for those without marrow involvement.
  • Only 4.7% of patients with AL amyloidosis achieved a complete cardiac recovery after nearly 10 years, linking this recovery to a survival rate akin to the general population.
  • Out of 42 older adults with late-life depression, 70% were found to have obstructive sleep apnea through home testing.
  • The introduction of linvoseltamab resulted in a response rate of 60% in patients with relapsed/refractory multiple myeloma, compared to just 20% for standard treatments.

Frequently asked questions

Does Dr. Siddiqui study multiple myeloma?
Yes, he conducts research on multiple myeloma, particularly focusing on treatment effectiveness and patient outcomes.
What are the key issues Dr. Siddiqui identifies for patients leaving the emergency department?
He identifies challenges such as understanding medical instructions and the lack of access to primary care as critical barriers for patients transitioning from emergency care.
How does Dr. Siddiqui's work relate to Alzheimer's disease?
His research looks at new compounds that could help protect brain function and memory in conditions resembling Alzheimer's, offering potential new treatment avenues.
What can be said about the risk of developing AL amyloidosis?
Dr. Siddiqui's studies show that patients with certain previous blood disorders are at a higher risk, with those showing elevated free light chains developing the disease sooner.
How can home testing help older adults with depression?
His research indicates that home testing can successfully identify undiagnosed obstructive sleep apnea in older adults, which is important for improving their mental health.

Publications in plain English

A global perspective on transitioning from pediatric to adult care in epilepsy.

2026

Epilepsia

Andrade DM, Jetté N, Chandran I, Patel P, Rubboli G +19 more

Plain English
This study looked at how young people with epilepsy move from children's healthcare to adult healthcare around the world. Out of 316 neurologists surveyed, only 9% had structured programs to help with this transition, while 59% either had no programs or weren't aware of any available resources. The findings highlight significant challenges, especially in poorer regions, such as a lack of funding and training, suggesting that better systems and support are urgently needed to ensure smoother transitions for these patients. Who this helps: This research benefits patients with epilepsy, their families, and healthcare providers by identifying gaps and suggesting improvements in care transitions.

PubMed

Lipid profile effects on donor and recipient of a domino liver transplant with heterozygous familial hypercholesterolemia.

2026

Journal of clinical lipidology

Poudyal D, Yakubu I, Kumaran V, Siddiqui M, Mayer SB

Plain English
This study looked at the effects of liver transplants in two women: a 34-year-old donor with a genetic condition called heterozygous familial hypercholesterolemia (HeFH) and a 49-year-old recipient with cancer. After the transplant, the donor's cholesterol levels improved so much that she no longer needed medication. Meanwhile, the recipient developed high cholesterol but not as severely as the donor had before the transplant, indicating that her body was still able to manage some of the cholesterol. This research is important because it shows that liver transplants can significantly help patients with high cholesterol and potentially improve the outcomes for cancer patients with liver issues. Who this helps: Patients with high cholesterol and cancer affecting the liver.

PubMed

Elevated non-clonal bone marrow plasma cell fraction at diagnosis is associated with improved outcomes in multiple myeloma.

2026

Blood cancer journal

Zanwar S, Jevremovic D, Kapoor P, Olteanu H, Buadi F +22 more

Plain English
This study looked at 798 patients newly diagnosed with multiple myeloma to see if a higher percentage of non-clonal plasma cells in their bone marrow (at least 5%) could predict better health outcomes. Those with a higher non-clonal plasma cell fraction had lower levels of disease-related cells in their bone marrow (20% compared to 50%), a higher chance of having a favorable genetic makeup, and significantly better 6-year survival rates (70.3% vs. 56.5%) compared to those with lower levels. This finding is important because it suggests that measuring non-clonal plasma cells at diagnosis could help doctors assess a patient’s prognosis more effectively. Who this helps: Patients diagnosed with multiple myeloma and their doctors.

PubMed

Sexually transmitted and blood-borne infections profile in a mid-sized Saskatchewan City.

2026

BMC public health

Medu O, Mahajan P, Bourget H, Hennink M, Benz C +4 more

Plain English
This study looked at sexually transmitted and blood-borne infections (STBBIs) in Regina, Saskatchewan, from 2019 to 2024. Researchers found a total of 11,739 cases, with syphilis cases sharply increasing, while chlamydia and gonorrhea cases decreased. This matters because the rise in syphilis and other infections poses ongoing public health challenges, highlighting the need for effective prevention and treatment programs. Who this helps: This research aids public health officials and healthcare providers in better understanding and managing STBBIs in the community.

PubMed

4-Chlorobenzylamine Containing Maleic Acid Derivatives: Synthesis,Studies, and Anti-Alzheimer's Activity.

2026

ACS chemical neuroscience

Tariq MJ, Kanwal M, Ata A, Nadeem H, Siddiqui M

Plain English
This study looked at new compounds made from maleic acid to see if they could protect the brain from memory loss caused by scopolamine, a substance that can trigger Alzheimer’s-like symptoms in rats. The researchers found that two specific compounds, 2a and 2f, showed strong antioxidant effects and helped reduce brain inflammation, leading to improved memory and behavior in the rats. Specifically, compound 2f worked effectively at very low concentrations (22.09 nM), helping to restore brain function. Who this helps: This research could benefit patients with Alzheimer's disease and their caregivers by potentially leading to new treatment options.

PubMed

Small modular nuclear reactors for developing countries: Expectations and evidence.

2026

PNAS nexus

Friess F, Siddiqui M, Ramana MV

Plain English
This study looked at the hopes of developing countries wanting to use small modular nuclear reactors (SMRs) for electricity. Researchers found that while officials expect SMRs to be cheap to build and operate, as well as beneficial for local manufacturing, the reality is different: SMRs are likely to be more expensive than traditional large nuclear plants, they aren't yet proven technology, and they don’t easily fit into local manufacturing plans due to the need for mass production. This matters because it highlights the challenges these countries may face in adopting SMRs for their energy needs. Who this helps: This information is valuable for policymakers and energy planners in developing countries.

PubMed

High-Content SRS Imaging Unveils Altered Cholesterol Metabolism in Ovarian Cancers Under CAR-T Treatment.

2026

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Prabhu Dessai CV, Huang Z, Lin H, Ding G, He H +4 more

Plain English
This study examined how ovarian cancer cells change their cholesterol metabolism when treated with CAR-T cell therapy, a promising treatment for some cancers. The researchers discovered that surviving ovarian cancer cells store more cholesterol and that using a drug called Avasimibe can make CAR-T treatment more effective. These findings are important because they suggest that altering the metabolism of cancer cells can improve treatment outcomes for patients with ovarian cancer. Who this helps: This benefits patients with ovarian cancer and their doctors.

PubMed

RGX-019-MMAE inhibits leukemia progression by targeting MER proto-oncogene tyrosine kinase (MERTK) in acute myeloid leukemia.

2026

Journal of experimental & clinical cancer research : CR

Tyagi A, Siddiqui M, Eckstrom A, Kurth I, Takeda S +9 more

Plain English
This study focused on a new treatment called RGX-019-MMAE, which targets a protein called MERTK that is found in high levels in certain types of acute myeloid leukemia (AML), particularly in patients with specific mutations. Researchers found that RGX-019-MMAE effectively killed leukemia cells in laboratory tests, showing a significant improvement in cell death compared to standard treatments, and it also helped extend the lives of mice with leukemia. This finding highlights MERTK as a valuable target for therapies against AML, particularly for patients with monocytic forms of the disease. Who this helps: Patients with acute myeloid leukemia (AML), especially those with high MERTK expression.

PubMed

Feasibility of home testing to detect undiagnosed obstructive sleep apnea in late life depression.

2026

Sleep medicine

Singh R, Berger S, Siddiqui M, Rapoport M, Herrmann N +3 more

Plain English
This study looked at whether older adults with late-life depression could effectively use home testing to identify obstructive sleep apnea (OSA), a condition that can worsen their depression. Out of 42 participants, 20 completed the home sleep apnea test, and 14 of them (70%) were found to have OSA, with 4 having moderate to severe cases. This is important because it shows that home testing can be a practical and accepted method to find undiagnosed OSA in older adults, which could lead to better treatment for their depression. Who this helps: This helps older adults with late-life depression who may have undiagnosed obstructive sleep apnea.

PubMed

Determinants of Gastrointestinal Disease Burden and Survival in Systemic AL Amyloidosis.

2026

Blood advances

Steinhardt MJ, Muchtar E, Kourelis TV, Warsame R, Mauermann ML +25 more

Plain English
This study looked at how gastrointestinal (GI) issues impact patients with systemic light chain amyloidosis (AL) and how these issues affect survival rates. Out of nearly 4,400 patients studied, 521 (about 12%) had GI symptoms, with early fullness, bowel problems, and nausea being very common. Those with serious GI complications, particularly involving multiple layers of the gut, had a much worse survival rate—around 2.4 years compared to 7.8 years for those with less severe involvement. Who this helps: This research benefits patients with systemic AL amyloidosis and their healthcare providers by highlighting the importance of monitoring GI symptoms and managing nutritional needs.

PubMed

Systematic review and meta-analysis of cervico-vaginal high-risk human papillomavirus prevalence in India prior to nationwide human papillomavirus vaccination.

2026

Archives of public health = Archives belges de sante publique

Adhikari I, Kataria I, Bhandari P, Siddiqui M, Basu P +3 more

PubMed

Miliary Tuberculosis With Gastrointestinal Involvement in a Young Undocumented Immigrant: A Case Report.

2026

Cureus

Khaleefah M, Parvizi D, Khaleefah K, Basith F, Bhullar KK +3 more

Plain English
This study examined a 31-year-old man who suffered from a severe form of tuberculosis that affected his lungs and digestive system. He experienced significant weight loss, vomiting, and extreme fatigue, and despite starting treatment, his condition quickly worsened, leading to his death just five days after being admitted to the hospital. This case emphasizes the critical need for early diagnosis and treatment of tuberculosis, especially for undocumented immigrants who may face additional barriers to healthcare. Who this helps: This helps patients with tuberculosis, particularly those who are undocumented immigrants.

PubMed

Cardiac Biomarker Complete Response in AL Amyloidosis: Characteristics, Cardiac Recovery, and Survival of 63 Patients.

2026

JACC. CardioOncology

Muchtar E, Geyer S, Dispenzieri A, Grogan M, Kourelis TV +23 more

Plain English
This study looked at 63 patients with a specific heart condition called AL amyloidosis to see how many achieved what’s called cardiac biomarker complete response (CR), which is a sign of heart recovery. The researchers found that 4.7% of patients (63 out of 1,342) reached this level of recovery over an average follow-up of nearly 10 years, with a significant increase in this rate over time. Achieving cardiac biomarker CR was linked to a survival rate similar to that of the general population, emphasizing the importance of diagnosing this condition early and treating it promptly, even though some heart issues may still remain. Who this helps: This helps patients with AL amyloidosis and their doctors understand the importance of monitoring heart recovery.

PubMed

A multi-center study of progression-risk and outcomes in solitary bone plasmacytoma with and without marrow involvement.

2026

Blood advances

Lim KJ, Steinhardt MJ, Rees MJ, Greipp PT, Kelemen K +42 more

Plain English
This study looked at two types of solitary bone plasmacytoma (SBP) – one with no involvement of the bone marrow (SBP) and one with minimal marrow involvement (SBPmm) – to understand their progression after treatment with radiation therapy. It found that 92% of SBPmm patients progressed to multiple myeloma compared to 76% of SBP patients, and patients with SBPmm had a median time to progression of only 15 months, while SBP patients had 43 months. This is important because it shows that SBPmm patients are at a much greater risk for fast progression to a more serious disease, suggesting that they may need different treatment approaches. Who this helps: This helps patients with SBPmm and their doctors by highlighting the need for closer monitoring and possibly earlier treatment.

PubMed

A multi-modal deep learning framework with GAN-based fusion for enhanced landslide detection.

2026

PloS one

Srivats R, Johnson DR, Logeswari G, Saimirra R, Siddiqui M +1 more

Plain English
This research focused on creating a new deep learning system to better detect and map landslides. The system combines four different neural networks, achieving impressive accuracy with scores of 97.24%, 93.70%, and 94.75% on three different testing datasets. This is important because it provides highly accurate and quick maps that can help in disaster response, allowing people to make faster decisions after landslides occur. Who this helps: This helps emergency responders and disaster management teams.

PubMed

Overlooking Barriers to Safe and Effective Emergency Department Discharge.

2026

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine

Hagerman TK, Mowbray FI, Lang T, Nour M, Rammal JK +5 more

Plain English
This study looked at how well emergency department doctors identify barriers that patients might face after being discharged, such as not having a primary care doctor or difficulty affording medications. Out of 234 patients surveyed, 20.4% reported not having a primary care provider, but only 9.8% of doctors recognized this issue. The findings highlight a significant gap in understanding patient needs, with doctors missing key barriers about 73.9% of the time, which indicates a need for better training and systematic approaches to patient care. Who this helps: This helps patients by ensuring they receive the support they need for safe recovery after an emergency department visit.

PubMed

Risk of AL Amyloidosis is Associated with Degree of Free Light Chain Elevation and Duration of Exposure.

2026

Research square

Dispenzieri A, Steinhardt M, Muchtar E, Kourelis T, Warsame R +22 more

Plain English
The study looked at how certain blood markers relate to the risk of developing a condition called AL amyloidosis, which can occur in some patients with blood disorders. The research included nearly 2,000 patients and found that those with higher levels of free light chains (dFLC) and a history of certain blood disorders were at greater risk, with a 10% chance of developing AL amyloidosis within 20 months if their dFLC was above 80 mg/dL. Understanding these risk factors can help doctors monitor patients better and potentially catch AL amyloidosis earlier. Who this helps: This helps patients with blood disorders and their doctors.

PubMed

Trends and Disparities in Cardiovascular Mortality among HIV-Positive Adults in the United States (2004-2020): A CDC WONDER Database Analysis.

2026

Current HIV research

Ahmed F, Rehman Mirza T, Eltawansy S, Aman K, Hurjkaliani S +8 more

Plain English
This study examined the links between cardiovascular disease (CVD) and HIV by analyzing death rates in HIV-positive adults from 2004 to 2020. It found that there were a total of 50,132 deaths related to both HIV and CVD, while 24,314,677 deaths were solely due to CVD. Between 2004 and 2020, the overall death rate from HIV and CVD combined decreased from 18.85 to 13.73 per million people, with the biggest declines seen among Black patients. Who this helps: This research can benefit HIV patients and healthcare providers by highlighting the need for targeted interventions to reduce mortality rates related to these diseases.

PubMed

A review of application of Artificial Intelligence in breast cancer detection and treatment.

2026

Discover oncology

Siddiqui A, Khobragade K, Kautish P, Siddiqui M, Marak Z

PubMed

Acute-on-chronic liver failure designation in patients with severe alcohol-associated hepatitis undergoing liver transplantation.

2026

Annals of hepatology

Houston K, Khan H, Alroobi H, Wadhwa N, Chadha N +18 more

Plain English
This study looked at patients with severe alcohol-related liver disease who were receiving liver transplants to see how often they were diagnosed with acute-on-chronic liver failure (ACLF). Researchers found that while ACLF is common in these patients, it's not diagnosed more often in those with severe alcohol hepatitis compared to other liver conditions. This is important because it shows that the current definitions for ACLF may miss how serious the disease really is in these patients, emphasizing the need for better diagnostic criteria. Who this helps: This helps doctors and patients with severe alcohol-related liver disease to ensure more accurate risk assessments and treatment options.

PubMed

Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma.

2026

Blood cancer journal

Kumar S, Jagannath S, Weisel KC, Rosiñol L, Leleu X +38 more

Plain English
This research studied the effectiveness of linvoseltamab, a new treatment for patients with multiple myeloma who have already gone through at least three previous therapies. The study found that linvoseltamab worked better than standard treatments, showing a 3 times higher response rate and longer survival times for patients. Specifically, patients treated with linvoseltamab had longer periods without their disease getting worse, taking an average of 5 to 7 months longer before needing another treatment, and overall survival improved by almost 30%. Who this helps: This benefits patients with advanced multiple myeloma who have limited treatment options.

PubMed

Effectiveness of linvoseltamab versus real-world standard-of-care in triple-class-exposed relapsed/refractory multiple myeloma in the United States.

2026

Blood cancer journal

Kumar S, Weisel KC, Spin P, Bonar N, Siddiqui M +16 more

Plain English
This study examined how well a new drug called linvoseltamab works compared to standard treatments for patients with a difficult-to-treat form of multiple myeloma who have already tried several therapies. The results showed that linvoseltamab led to a significantly better response rate, with patients experiencing better survival outcomes and longer periods without disease worsening. Specifically, patients treated with linvoseltamab had a response rate that was almost four times higher than standard care and lived longer without cancer progression. Who this helps: This benefits patients with relapsed/refractory multiple myeloma who have exhausted other treatment options.

PubMed

Nuanced effects of relative body size on social motivation in a highly gregarious catfish.

2025

Behavioural processes

Jungwirth A, Kern JN, Siddiqui M, Chiang A, Eisen N +3 more

Plain English
This study looked at how body size, familiarity, and environment affect social behavior in a type of catfish that loves to socialize. Researchers found that smaller catfish nudged their larger partners more often, especially when the fish didn’t know each other but shared the same diet; for example, a smaller fish nudged its larger partner nearly twice as often in unfamiliar settings. Understanding these dynamics helps us learn why these fish form diverse groups in nature. Who this helps: This benefits biologists and researchers studying animal behavior and social structures in aquatic environments.

PubMed

Improved survival with daratumumab-CyBorD compared with CyBorD as frontline therapy for AL amyloidosis.

2025

Blood neoplasia

Yohannan B, Rees M, Gertz MA, Dispenzieri A, Kapoor P +19 more

Plain English
This study looked at two treatment methods for patients with AL amyloidosis, a serious condition caused by the build-up of proteins in organs. Researchers found that patients receiving a treatment that included daratumumab along with standard drugs had much better outcomes—60.8% achieved a strong initial response compared to just 31.1% of those who didn't have daratumumab. This improved treatment not only led to fewer deaths (8.8% with daratumumab vs. 16.3% without) but also increased the chances of surviving without disease progression. Who this helps: This study benefits patients with AL amyloidosis, offering them a more effective treatment option that can lead to better health outcomes.

PubMed

Survival strategies of imipenem-resistant P. aeruginosa: a comparative analysis of surface-bound biofilms and unbound aggregates.

2025

The Journal of antibiotics

Saleem M, Siddiqui M, Ul Huda HN, Urooj S, Jabeen B +6 more

Plain English
This study looked at how imipenem-resistant Pseudomonas aeruginosa, a dangerous bacterium found in some ready-to-eat foods, survives and forms clusters called biofilms. Researchers found that after 96 hours in a lab setting, the biofilms were more resilient and could endure higher temperatures compared to free-floating clusters. Specifically, surface-bound biofilm cells were tougher and stuck better to surfaces than the unbound aggregates. Who this helps: This research benefits food safety experts and healthcare providers by highlighting how bacteria can resist treatment and persist in food products.

PubMed

Laetiporus sulphureus mushroom culture - source of secondary metabolites, and as a catalyst for biotransformation of breast cancer drug exemestane.

2025

Steroids

Yusifova Y, Atia-Tul-Wahab, Choudhary MI, Siddiqui M, Khan N +4 more

Plain English
This study looked at a specific mushroom called Laetiporus sulphureus and its potential to produce useful compounds for treating breast cancer. Researchers found that two new compounds isolated from the mushroom, along with a modified version of the breast cancer drug exemestane, could effectively inhibit aromatase, an enzyme related to estrogen production. The inhibition strengths of these compounds were significant, with values of 590 nM and 337.5 nM, compared to exemestane's 210 nM, suggesting they could be promising alternatives for treating estrogen receptor-positive breast cancers. Who this helps: This research benefits breast cancer patients, especially those with hormone-sensitive tumors.

PubMed

Caffeine: A Neuroprotectant and Neurotoxin in Traumatic Brain Injury (TBI).

2025

Nutrients

Sharma B, Agriantonis G, Dawson-Moroz S, Brown R, Simon W +16 more

Plain English
This study looked at how caffeine affects people with traumatic brain injuries (TBI). Researchers found that while caffeine can help reduce brain swelling and improve alertness for recovery, it can also cause problems if taken in high doses, especially in young adults who have had multiple mild TBIs. This is important because it shows that caffeine can be both helpful and harmful, depending on the situation. Who this helps: This helps patients recovering from brain injuries and the doctors treating them.

PubMed

From CyBorD to dara-CyBorD, ASCT utilization trends in AL amyloidosis: a 15-year analysis.

2025

Blood advances

Muchtar E, Dispenzieri A, Buadi FK, Kapoor P, Dingli D +15 more

Plain English
This study looked at how the use of a treatment called autologous stem cell transplantation (ASCT) for light chain amyloidosis has changed over 15 years at the Mayo Clinic. It found that between 2010 and 2024, the number of ASCT procedures dropped significantly, from 385 in the first period (2010-2019) to just 56 in the second period (2020-2024), which is a 71% annual decrease. This shift occurred because more patients were older, had more serious disease, and were using newer treatments that led to better responses before ASCT. Who this helps: This benefits patients with AL amyloidosis by providing more tailored treatment options.

PubMed

Lymphocyte Kinetics and Outcomes of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma With Out of Specification Products.

2025

American journal of hematology

Dingli S, Rothweiler P, Binder M, Cook J, Gertz MA +9 more

PubMed

Impaired mitochondrial metabolism is a critical cancer vulnerability for MYC inhibitors.

2025

Science advances

Yang W, Guo Q, Quan S, Chalmers ZR, Parker JB +13 more

Plain English
This study focused on a new drug called MYCi975 that targets a protein linked to aggressive cancers known as MYC. Researchers discovered that when they used MYCi975 alongside treatments that disrupt a part of the cell's energy production system (specifically complex I), tumors became more sensitive to the treatment, leading to better immune cell infiltration. The findings highlight how understanding cancer metabolism can help develop more effective treatment strategies for patients with MYC-driven cancers. Who this helps: This benefits cancer patients, particularly those with MYC-driven tumors.

PubMed

Complete renal duplication with lower pole obstructive ectopic ureter - An exception of the Weigert-Meyer rule.

2025

Urology case reports

Siddiqui M, Baskar A, Jafar Y, McGrath M, Braga LH

Plain English
This study looked at a rare case of a baby boy with a unique problem in his urinary system, where the lower part of one kidney was blocked, which is not how things usually work according to typical medical rules. They found that the baby had a severe infection and a blockage in that lower part, requiring surgery to remove the damaged kidney part. This case highlights the importance of tailoring treatment for patients with unusual kidney issues. Who this helps: This helps doctors treating patients with complex urinary system problems.

PubMed

Zyxin directly binds to chromosomal DNA and is linked with mitochondrial integrity and apoptosis.

2025

Biochemistry and cell biology = Biochimie et biologie cellulaire

Siddiqui M, Wojewodzic M, Sanghvi S, Pereira H, Vasudeva G +8 more

Plain English
This study investigated how a protein called zyxin interacts with DNA in cancer cells, specifically looking at prostate cancer. The researchers found that zyxin binds directly to DNA related to mitochondria, which are the energy-producing parts of cells. When zyxin levels were decreased, it led to changes in gene activity and increased signs of cell death, highlighting its important role in maintaining cell health and function. Who this helps: This helps cancer patients and doctors by improving understanding of cancer cell behavior and potential treatment targets.

PubMed

Assessment of the Children's Hospital of Philadelphia Score Algorithm for Screening Retinopathy of Prematurity in Premature Infants in Saudi Arabia.

2025

Nigerian journal of clinical practice

Raffa LH, Bawajeeh N, Alothman RA, Siddiqui M, Almarzouki HS

Plain English
This study looked at how well the Children's Hospital of Philadelphia Score Algorithm (CHOP-ROP) predicts retinopathy of prematurity, a condition that can cause blindness in premature infants, in Saudi Arabia. They found that 22.3% of the 524 preterm infants studied had some stage of retinopathy, and 9.1% needed treatment. The CHOP-ROP model was the most accurate at identifying which infants required treatment, but it missed some cases that other models caught, meaning some infants might not get the help they need. Who this helps: This helps doctors and healthcare providers improve screening for high-risk premature infants.

PubMed

Optimizing Cardiovascular Care in Aging Populations: A Comprehensive Review of Geriatric Cardiology.

2025

Cureus

Agarwal S, Ozor IN, Chithanuru S, Odumosu EO, Fadiora OE +7 more

Plain English
This study reviewed recent research on how to improve heart care for older adults, specifically looking at issues like multiple health problems, mental decline, and complex treatments. It found that using team-based care that addresses a variety of patient needs can lead to better health outcomes and a higher quality of life. For instance, traditional methods may struggle with older patients who often have several illnesses, so newer, more integrated approaches are needed. Who this helps: This helps older patients and their healthcare providers.

PubMed

Antioxidant, Protein-Binding, and Copper(II) Ion Sensing Activities ofPhytochemicals: An Integrated Experimental and Computational Study.

2025

ACS omega

Parveen M, Uzma, Khan AA, Wan Fauzi WND, Abd Kadir NH +2 more

Plain English
This study explored the chemical properties of plants from the Rhus genus, identifying two new compounds, Ra-01 and Ra-02, along with five others that have known effects. The researchers found that Ra-01 binds to proteins in both human and cow blood, indicating potential for use in health applications, while Ra-02 could be useful for detecting copper ions in solutions. Overall, these findings highlight the potential of these compounds for developing new health-related tools and therapies. Who this helps: This research benefits scientists and healthcare providers looking for new diagnostic and treatment options.

PubMed

Expression of Concern for Elevated circulating amyloid concentrations in obesity and diabetes promote vascular dysfunction.

2025

The Journal of clinical investigation

Meakin PJ, Coull BM, Tuharska Z, McCaffery C, Akoumianakis I +14 more

PubMed

Cholesterol metabolism modulation facilitates CAR-T induced killing of ovarian cancer.

2025

bioRxiv : the preprint server for biology

Dessai CVP, Huang Z, Lin H, Ding G, He H +4 more

Plain English
This research looked at how ovarian cancer cells respond to CAR-T cell therapy, a promising treatment for some cancers. The study found that the cancer cells that survived the therapy changed their cholesterol metabolism, storing excess cholesterol, which helped them resist the treatment. By using a drug called Avasimibe to block this storage, the researchers were able to make the CAR-T therapy more effective. This matters because it highlights a new way to improve cancer treatment for solid tumors like ovarian cancer, which is notoriously difficult to treat. Who this helps: Patients with ovarian cancer may benefit from improved treatments through this research.

PubMed

Multicancer Detection Tests for Screening : A Systematic Review.

2025

Annals of internal medicine

Kahwati LC, Avenarius M, Brouwer L, Crossnohere NL, Doubeni CA +5 more

Plain English
This research looked at blood tests that can detect multiple types of cancer in people who don't show symptoms. The findings showed that while some tests had high sensitivity (the ability to correctly identify cancer) ranging from about 9.5% to 99.8%, the results varied widely, and no studies proved that these tests effectively reduced cancer deaths or improved quality of life. This matters because better screening methods could lead to earlier cancer detection and treatment, which might save lives. Who this helps: This helps patients, especially those at risk for multiple types of cancer.

PubMed

A Roadmap to Excellence: Insights From Quality Structures of Top-Performing Healthcare Organizations.

2025

American journal of medical quality : the official journal of the American College of Medical Quality

Cerese J, Chang P, Graves K, Grubeling N, Ikezuagu M +6 more

Plain English
This study looked at what makes healthcare organizations highly effective by analyzing over 20 years of research. It found that the best organizations set clear goals that everyone can contribute to while encouraging teamwork across different departments like patient safety and data analytics. They also adapt quickly to new needs in healthcare, ensuring they always provide top-quality care. Who this helps: This benefits patients and healthcare providers by improving the overall quality of care.

PubMed

Spinal Cord Stimulation to Treat Chronic Abdominal Pain Secondary to Celiac Artery Compression Syndrome: A Case Report.

2025

A&A practice

Siddiqui M, Zhang H

Plain English
This study focused on a patient with chronic abdominal pain caused by celiac artery compression syndrome (CACS) who could not undergo surgery. Using spinal cord stimulation (SCS), the patient experienced an 80% reduction in pain and improved physical activity after a 10-day trial followed by permanent implantation of the device. This is significant because it shows that SCS can be an effective non-surgical treatment option for managing severe pain in patients with this condition. Who this helps: Patients suffering from chronic abdominal pain due to celiac artery compression syndrome.

PubMed

Mending the Gap: A Systematic Review and Meta-Analysis of Mesh Reinforcement for Abdominal Wall Closure in Abdominal Aortic Aneurysm (AAA) Repair.

2025

Cureus

Ahmad S, Ahmad MU, Zeidaabadi B, Siddiqui M

Plain English
This study looked at how using mesh during surgery can help prevent hernias after fixing abdominal aortic aneurysms (AAAs). Researchers found that using mesh cut the chance of developing a hernia by 87%, but those who had mesh were also over seven times more likely to develop fluid collections called seromas. This is important because while mesh can help people avoid hernias, it also brings a higher risk of other complications, so doctors need to carefully consider both the benefits and risks when deciding how to perform these surgeries. Who this helps: This helps patients undergoing AAA repair and their doctors.

PubMed

Donor-Derived Vγ9Vδ2 T Cells for Acute Myeloid Leukemia: A Promising "Off-the-Shelf" Immunotherapy Approach.

2025

Cancers

Eckstrom A, Tyagi A, Siddiqui M, Borgman J, Zeng J +3 more

Plain English
This study explored the use of a specific type of immune cell, called Vγ9Vδ2 T cells, as a treatment for patients with acute myeloid leukemia (AML), especially those who do not respond to a common drug, venetoclax. The researchers found that these T cells could effectively kill AML cells, including those that are resistant to venetoclax, and treatment with these cells improved survival in laboratory models of AML. This approach is important because it offers a new option for patients who currently have very few effective treatments available. Who this helps: This benefits patients with acute myeloid leukemia, particularly those resistant to existing therapies.

PubMed

Isolation and comprehensive characterization of a bioactive compound from: single-crystal X-ray diffraction, antioxidant, protein-binding, and chemosensing studies.

2025

RSC advances

Uzma, Parveen M, Fatima S, Kumar A, Azeem M +2 more

Plain English
This study focused on isolating and examining the properties of three beneficial compounds from a specific plant's leaves, one of which, called bergenin, was identified for the first time from this plant. The researchers found that bergenin has strong antioxidant effects and binds effectively to a protein important for drug delivery in the body, showing better binding abilities compared to other known substances. These findings are important because they highlight bergenin as a promising candidate for developing new treatments due to its various health benefits. Who this helps: Patients looking for new antioxidant treatments and doctors seeking alternative therapeutic options.

PubMed

Targeting GD2 with naxitamab overcomes GD3 synthase-driven immune suppression in triple-negative breast cancer.

2025

NPJ breast cancer

Anand V, Oderinde B, Siddiqui M, Tyagi A, Borgman J +3 more

Plain English
Researchers studied a specific enzyme called GD3 synthase that is linked to immune suppression in a type of breast cancer called triple-negative breast cancer (TNBC). They found that this enzyme reduces the ability of immune cells to fight tumors, but when they treated the cancer with a drug called naxitamab, it boosted the immune response and slowed tumor growth. This matters because it shows a new way to potentially improve treatment for a very aggressive form of breast cancer. Who this helps: This benefits patients with triple-negative breast cancer.

PubMed

The SOFA score as a mortality predictor in ICU patients: insights from a tertiary care hospital in Pakistan.

2025

BMC research notes

Shariq T, Rahman AS, Jamal Q, Siddiqui M, Khan U +1 more

Plain English
This study looked at how well the SOFA score, which measures organ dysfunction, predicts death in seriously ill patients in an ICU at a hospital in Karachi, Pakistan. They found that for every point increase in the SOFA score, the chances of survival dropped by 13%, and older patients faced a 2% higher risk of death for each additional year of age. Additionally, patients with obesity had more than double the odds of dying compared to those with a lower weight. Who this helps: This research benefits doctors and medical staff by providing them with important information to improve treatment decisions for critically ill patients.

PubMed

A systematic review and meta-analysis on the use of diagnostic ultrasound in guiding corticosteroid injections for shoulder pain (subacromial/ subdeltoid bursa).

2025

JPMA. The Journal of the Pakistan Medical Association

Khan AS, Khan M, Siddiqui M, Khan AA, Rao M

Plain English
This study looked at how well ultrasound-guided corticosteroid injections help reduce shoulder pain caused by issues like subacromial impingement or bursitis. The researchers found that these injections were effective in relieving pain shortly after treatment, with significant improvements in pain levels at 6 weeks and better shoulder movement, particularly in flexion and rotation. However, the long-term benefits are unclear because the studies varied widely and didn't track patients for long periods. Who this helps: This helps patients suffering from shoulder pain and their healthcare providers looking for effective treatments.

PubMed

Formative research and design for a mobile health platform for oral cancer screening and detection (OC-DETECT)-a mixed methods study.

2025

Frontiers in digital health

Isaacs KR, Birur PN, Siddiqui M, Patel K, Greene AI +6 more

Plain English
This study focused on developing a mobile health platform aimed at screening and detecting oral cancer in India, where oral cancer is a major health issue. Researchers engaged with healthcare providers and young people to gather insights on their awareness of oral health, barriers to seeking treatment, and acceptance of using a mobile app for health screening. The results indicated strong interest in the app, particularly among young adults, but highlighted concerns about privacy and a general lack of awareness regarding oral health issues. Who this helps: This benefits patients at risk for oral cancer and healthcare providers looking to improve screening efforts.

PubMed

Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greater Gulf Region (REPAIR Study).

2025

Frontiers in oncology

Alhejazi A, Alhuraiji A, Nourallah A, Alshehri A, Usman B +20 more

Plain English
The study looked at how patients with relapsed multiple myeloma—the cancer of plasma cells—are treated in the Gulf region, focusing on their treatment responses and any kidney or lung problems. Researchers analyzed records from 148 patients and found that the most common first treatment was a combination of three drugs (Bortezomib, Lenalidomide, and Dexamethasone), with 52.7% of patients being eligible for stem cell transplants. Importantly, while kidney issues decreased with treatment, lung complications increased significantly, showing that managing this disease comes with various challenges. Who this helps: This research benefits patients and doctors by providing insights into effective treatments and the complications they may face.

PubMed

Faster Thrombolysis Is Associated With Improved Cognitive Outcomes in Patients With Acute Ischemic Stroke Treated With Alteplase and Tenecteplase: A Substudy of the AcT Trial.

2025

Stroke

Sujanthan S, Rajkumar G, Dainty KN, Barense M, Lanctot KL +26 more

Plain English
This study looked at how quickly patients with acute ischemic stroke received treatment and how that affected their cognitive abilities three to six months later. Researchers found that reducing the time from when symptoms started to when treatment was given improved cognitive scores; specifically, each 15-minute decrease in this time lowered the chance of cognitive impairment by 7.3%. This is important because better cognitive outcomes can lead to improved overall recovery and quality of life after a stroke. Who this helps: Patients who suffer from acute ischemic strokes.

PubMed

Whole-head high-density diffuse optical tomography to map infant audio-visual responses to social and non-social stimuli.

2024

Imaging neuroscience (Cambridge, Mass.)

Collins-Jones LH, Gossé LK, Blanco B, Bulgarelli C, Siddiqui M +10 more

Plain English
This study focused on a new method called whole-head high-density diffuse optical tomography (HD-DOT) to measure brain activity in infants aged 5 to 7 months while they responded to social and non-social cues. Researchers tested this method on 16 infants and were able to map brain activity across the entire head, revealing activation in several areas of the brain that previous methods missed. These findings are important as they could lead to better understanding of brain development in infants, helping identify both typical and atypical patterns of growth. Who this helps: This helps researchers and healthcare providers working with infants, especially those monitoring brain development.

PubMed

Frequent Co-Authors

David Dingli Prashant Kapoor Rahma Warsame Joselle Cook Moritz Binder Angela Dispenzieri Eli Muchtar Nelson Leung Yi Lin Morie A Gertz

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.